Disc Medicine, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Disc Medicine, Inc. (IRON) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.87 million shares for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2022-11-10
- Disc Medicine, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 6.75M shares, a 20.51% increase year-over-year.
- Disc Medicine, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-03-31 was 5.60M shares, a 153.09% increase year-over-year.
- Disc Medicine, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-03-31 was 2.21M shares.
- Disc Medicine, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 6.32M shares, a 166.81% increase from fiscal 2020.
- Disc Medicine, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 2.37M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2022-09-30 | 3.87M shares 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 5.68M shares 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 6.75M shares 10-Q · filed 2022-05-06 | |||
| 2021-12-31 | 6.32M shares 10-K · filed 2022-03-10 | |||
| 2021-09-30 | 4.99M shares 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 6.51M shares 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | 5.60M shares 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | 2.37M shares 10-K · filed 2022-03-10 | |||
| 2020-09-30 | 1.99M shares 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | 2.09M shares 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | 2.21M shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |